Figure 2.
Cumulative incidence of msCRFS (A), NRM (B), FFS (C), and OS (D). msCRFS was analyzed starting 120 days after HCT, whereas all other outcomes were analyzed since the date of cGVHD onset.

Cumulative incidence of msCRFS (A), NRM (B), FFS (C), and OS (D). msCRFS was analyzed starting 120 days after HCT, whereas all other outcomes were analyzed since the date of cGVHD onset.

Close Modal

or Create an Account

Close Modal
Close Modal